G
Geneus
Nanopore sequencing and energy storage solutions for IoT and portable electronics
About Geneus
Geneus Technology operates in the field of advanced materials and biotechnology, focusing on nanopore sequencing and energy storage solutions. The company collaborates with the Shanghai Institute of Health Research to accelerate the development of nanopore sequencing technologies, which are crucial for rapid and accurate genetic analysis. Additionally, Geneus Technology is involved in the enhancement of energy storage devices, particularly through the use of in situ grown titanium nitride and titanium oxynitride laminated thin films. These materials are designed to improve the power density and efficiency of supercapacitors, making them ideal for applications in wireless IoT systems, MEMS, and portable electronics. The business model likely involves partnerships with research institutions and technology companies, generating revenue through the development and licensing of proprietary technologies. Geneus Technology serves clients in the biotechnology and electronics sectors, addressing the growing demand for efficient energy storage and advanced genetic analysis tools.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2025 | $14M | $55M | Sichuan Innovation Development Investment Management · Chengdu Bio-Town Investment | ↗ |
| SERIES B✓Equity / VC | Mar 2023 | $0 | — | Zhejiang DIAN Diagnostics · GF Xinde Investment · Wanyuan Fund | ↗ |
Growth signals
Latest recorded traffic for Geneus is 3.3K monthly website visits, up 120% over the last three months. Geneus's team grew 66.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A10 investors entered at this stage
China Growth Capital
Sequoia- RCRays Venture Capital
- SCSinopharm Capital
- PCPotential Capital
- ZDZhejiang DIAN Diagnostics
- GIGF Xinde Investment
- WFWanyuan Fund
- CIChengdu Bio-Town Investment
- SMSichuan Innovation Development Investment Management
Other known investors1 additional known investor
HSG
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Geneus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Geneus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







